China Pharma Holdings Announces $6.3 Million Private Placement via Unregistered Share Sale
I'm PortAI, I can summarize articles.
China Pharma Holdings Inc. announced a $6.3 million private placement through the issuance of 3.5 million restricted shares at $1.80 each. The shares, issued under Regulation S, are payment for a technology transfer agreement involving Captopril microcapsules. The transaction is exempt from registration under the Securities Act.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments